Thioredoxin Systems AB: TXN Systems Raises SEK 25 Million Series A to Advance First-in ...
EbsArgent targets urinary tract infections, with early indications of efficacy against many species of multidrug-resistant bacteria STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- Thioredoxin ...